The Enterprise Value as of December 2025 (TTM) for Pacira BioSciences, Inc. (PCRX) is 952.95M

According to Pacira BioSciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 952.95M. This represents a change of -25.97% compared to the average of 1.29B of the last 4 quarters.

Pacira BioSciences, Inc. (PCRX) Historical Enterprise Value (quarterly & annually)

How has PCRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Pacira BioSciences, Inc. over the last ten years is 2.20B. The current 952.95M Enterprise Value has changed 4.23% with respect to the historical average. Over the past ten years (40 quarters), PCRX's Enterprise Value was at its highest in in the March 2022 quarter at 4.20B. The Enterprise Value was at its lowest in in the September 2025 quarter at 997.02M.

Pacira BioSciences, Inc. (PCRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pacira BioSciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pacira BioSciences, Inc. (PCRX) Average Enterprise Value

How has PCRX Enterprise Value performed in the past?

The current Enterprise Value of Pacira BioSciences, Inc. (PCRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Pacira BioSciences, Inc. (PCRX) Enterprise Value vs. Peers

How is PCRX’s Enterprise Value compared to its peers?

Pacira BioSciences, Inc.’s Enterprise Value is greater than Cronos Group Inc. (166.09M), less than AnaptysBio, Inc. (1.10B), less than Xencor, Inc. (1.46B), greater than Oculis Holding AG (765.23M), less than UroGen Pharma Ltd. (1.17B), less than Kodiak Sciences Inc. (1.30B), less than Tandem Diabetes Care, Inc. (1.76B), greater than BridgeBio Oncology Therapeutics Inc. (517.22M), greater than Mind Medicine (MindMed) Inc. (919.17M), greater than Phathom Pharmaceuticals, Inc. (913.24M),

Build a custom stock screener for Pacira BioSciences, Inc. (PCRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacira BioSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pacira BioSciences, Inc. (PCRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pacira BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.